Media mentions

For media enquiries, please contact

Rob Clancy
Communications and Media Manager
m: +61 0 408 579 313
ecommunications@hudson.org.au


Media 2021

October

Noxopharm well-funded to advance “rapidly expanding” clinical program
Proactive Investors

Invion, Dimerix, Orthocell: Promising ASX stocks to watch amid biotech boom
Kalkine Media

Hearts in the right place
CEO Sydney

September

Renowned Scientists Added To Scientific Advisory Group
Premier of VIC

Hearts in the Right Place: Thian Chew
CEO Magazine

How Do Bats Resist COVID? Insights Could Lead to New Treatments for Humans
Herald Sun
UKTodayNews
SciTechDaily
California New Times
USA Newsguru
EurekAlert
LeakHerald
Fiercebiotech
Earth

A GP guide to primary aldosteronism
Australian Doctor Group

Research team lead by Dr Jim Vadolas develops viral gene therapy to treat beta thalassaemia
Neos Kosmos

Invion advances ‘exciting’ photodynamic therapy to treat a range of cancers
Small Caps

Global female scholars award opens for 2022
BiotechDispatch

Can Invion’s promising technology do more than just treat cancer patients?
Kalkline Media

Viruses and the COVID-19 pandemic
Radio | 2NUR

August

Noxopharm Preclinical Data Further Supports Anti-Inflammatory Role of Idronoxil in the Treatment of COVID-19
Street Insider
Galv News
Yahoo Finance

Coffee sellers a sign of pandemic desperation | Covid-19 research
The Australian

Breathing support improves lung function in near-term newborns
Today UK News

Invion Group to expand its promising photodynamic therapy technology into new markets
Small Caps

Noxopharm’s Veyonda® may offer other therapeutic opportunities in chronic inflammatory and autoimmune diseases
Proactive Investors
Yahoo Finance

July

Geelong MPs questioned on whether they will donate their minimum pay rise to charity
Herald Sun
Geelong Advertiser

Australian biotech submits for approval of world first microbial therapy
News for Business
Medianet
Pharmacy ITK

June

Maria Alexiadis OAM: Part-time scientist, part-time Kumite sensei
Greek Herald

New drugs may kill and limit reproduction of bowel cancer cells
TV | 9 News
Radio | 2GB
InSight+

Photodynamic therapy to reduce tumours
The Pulse

May

Moderna ‘toxic’ vaccine claim a potent dose of misinformation
AAP

Monash team co-develop lung disease drug
Herald Sun
Geelong Advertiser
Adelaide Advertiser

For International HR day, we’re celebrating HR initiatives that help businesses thrive
HRM – Australian HR Institute News

What 2,000-year-old poo says about our gut bugs
ABC

Breakthrough discovery for women suffering after traumatic childbirths
TV | 7NEWS
Radio | ABC, 5AA
Herald Sun
Courier Mail

Developing early detection test for Ovarian cancer
TV | 7NEWS
TV | 10NEWS

Protecting premature babies | discussing an often fatal disease called necrotising enterocolitis (NEC)
ABC Babytalk podcast

April

Noxopharm’s interim trial data indicates Veyonda® potentially prevents cytokine storm in patients with moderately severe COVID-19 
Proactive
Biotech

March

Australian scientists new world-first sperm discovery
TV | National Nine News
Radio | ABC Newcastle

Tackling Ovarian Cancer
Australian Jewish News

Victorian Women Leading COVID-19 Research Charge
Premier of Victoria

Walk For a Worthy Cause
Crandbourne News

February

Ovarian Cancer: Hope on the Horizon
Tonic magazine

A head start on migraine treatment
The West Australian

January

Building A Case To Beat The World’s Deadliest Diseases
Premier of Victoria

Hon Jaala Pulford visits Hudson Institute
Mirage News

Noxopharm says study advancing after clinical review
BiotechDispatch